In a randomized controlled trial of patients with the three conditions who were already taking second-generation antipsychotic medication, those who also received 30 weeks of semaglutide at a dose of up to 1 mg/wk had a weight reduction of 20 lb compared with those receiving a placebo, as well as a greater reduction in blood glucose and triglycerides
2007 Jul;30(7):834-9., The effect of tripeptide-copper complex on human hair growth in vitro
Short intestine is a possible long-term complication, requiring complex nutritional management in these patients
Your prescribing clinician should review your progress, including dietary habits, at follow-up appointments
Semaglutide typically results in an average weight loss of about 15% of body weight, while Tirzepatide often leads to more substantial weight loss, with some individuals losing around 20% of their body weight
Since semaglutide enhances insulin release and blood sugar control, any factor affecting insulin sensitivity could theoretically influence the drugs efficacy